Insilico's AI-designed fibrosis drug cuts predicted biological age by ~3 years
Polymarket · x · 2026-09-09
Insilico Medicine says its AI-designed fibrosis drug produced an average 3-year drop in predicted biological age among participants, prompting the company to claim "we might have a chance to stop biological aging." Details on sample size and mechanism are not yet disclosed.
More from Research
- NumeriaPlus: 300-hour egocentric activity dataset with dense ground truth for world models — ducha_aiki · 2026-09-09
- OpenAI claims 10,000 agents proved Navier-Stokes blowup in 88 hours; Clay Institute won't accept it — AdaptiveAgents · 2026-09-09
- Programmable Cellular Automata: readable code rules evolved via genetic programming — Amidos2006 · 2026-09-09
- Light REACT trains robots to adapt on the fly to hardware damage — chris_j_paxton · 2026-09-09
- One global function cuts Sokoban evolution iterations from ~98 to 7-24, finds LLM level-gen study — Amidos2006 · 2026-09-09
- LLM-evolved game levels: one global function takes Zelda playability from ~0% to ~100% — Amidos2006 · 2026-09-09